Study details
Enrolling now
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
Memorial Sloan Kettering Cancer Center
NCT IDNCT06637462ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 3 years
Ages
18+
Locations
6 sites in NJ, NY
What this study is about
Researchers are testing how people with rectal cancer respond to standard treatment (chemoradiation and chemotherapy) before surgery. The trial will use blood, tissue, and scan results to see if the response to this treatment can predict whether a person's cancer gets better, worse, or stays the same after treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Endoscopy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Clinical response
Procedures
diagnostic
Body systems
Oncology